Charles Schwab Investment Management Inc Protara Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
39Shares Held
10.7MCall Options Held
9KPut Options Held
1.8K-
Ra Capital Management, L.P. Boston, MA1.9MShares$4.35 Million0.05% of portfolio
-
Opaleye Management Inc. Boston, MA1.68MShares$3.85 Million0.56% of portfolio
-
Stem Point Capital LP New York, NY943KShares$2.16 Million0.52% of portfolio
-
Woodline Partners LP San Francisco, CA852KShares$1.95 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA812KShares$1.86 Million0.08% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $25.8M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...